Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterus Disorder”

5,543 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,543 results

Large-scale testing (Phase 3)Study completedNCT01097252
What this trial is testing

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical Cancers
Korea Cancer Center Hospital 104
Not applicableStudy completedNCT02083848
What this trial is testing

Detection of Loco-regional Invasion of Cervical Cancer With 7 Tesla MRI

Who this might be right for
Cervical Cancer
UMC Utrecht 23
Very early researchActive Not RecruitingNCT04219904
What this trial is testing

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Who this might be right for
Stage IA Cervical CancerStage IA1 Cervical CancerStage IA2 Cervical Cancer+4 more
M.D. Anderson Cancer Center 25
Large-scale testing (Phase 3)Ended earlyNCT03400943
What this trial is testing

Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)

Who this might be right for
Uterine Fibroids
Bayer 93
Not applicableStudy completedNCT00003598
What this trial is testing

UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia

Who this might be right for
Cervical CancerPrecancerous/Nonmalignant Condition
University of Michigan Rogel Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT01941316
What this trial is testing

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Who this might be right for
Small Cell Lung CarcinomaNon Small Cell Lung CarcinomaIrinotecan Sensitive Cancers
Cancer Research and Biostatistics Clinical Trials Consortium 78
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT00335998
What this trial is testing

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Who this might be right for
Recurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)UnknownNCT03725306
What this trial is testing

Librata Endometrial Ablation Device Treatment to Reduce Menstrual Blood Loss

Who this might be right for
MenorrhagiaHeavy Menstrual Bleeding
LiNA Medical 200
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Not applicableWithdrawnNCT01380158
What this trial is testing

Preventing Preterm Birth With a Pessary

Who this might be right for
Preterm Birth
Medstar Health Research Institute
Not applicableLooking for participantsNCT07527143
What this trial is testing

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
Mayo Clinic 25
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT04951921
What this trial is testing

Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT Therapy

Who this might be right for
Cervical Cancer
Chang Gung Memorial Hospital 6
Early research (Phase 1)Study completedNCT03578406
What this trial is testing

HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer

Who this might be right for
Cervical CancerHead and Neck Squamous Cell Carcinoma
Xinqiao Hospital of Chongqing 9
Not applicableLooking for participantsNCT06398938
What this trial is testing

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

Who this might be right for
Locally Advanced Cervical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 129
Not applicableUnknownNCT01710085
What this trial is testing

Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients

Who this might be right for
Cervical CancerEndometrial Cancer
Uludag University 100
Not applicableStudy completedNCT02486471
What this trial is testing

Hemostatic Procedure After Biopsy of the Cervix

Who this might be right for
Uterine Cervical Dysplasia
Zydolab - Institute of Cytology and Immune Cytochemistry 166
Not applicableStudy completedNCT04025658
What this trial is testing

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With Twin Pregnancy

Who this might be right for
Postpartum HemorrhageTwin
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 30
Next Page